User menu

Reduced histone deacetylase 7 activity restores function to misfolded CFTR in cystic fibrosis.

Bibliographic reference Hutt, Darren M ; Herman, David ; Rodrigues, Ana P C ; Noël, Sabrina ; Pilewski, Joseph M ; et. al. Reduced histone deacetylase 7 activity restores function to misfolded CFTR in cystic fibrosis.. In: Nature Chemical Biology, Vol. 6, no.1, p. 25-33 (2010)
Permanent URL http://hdl.handle.net/2078/119719
  1. Riordan J.R., Annu. Rev. Biochem., 77, 701 (2008)
  2. Qu B.H., J. Biol. Chem., 272, 15739 (1997)
  3. Boucher R.C., J. Intern. Med., 261, 5 (2007)
  4. Balch W.E., Science, 319, 916 (2008)
  5. Powers E.T., Annu. Rev. Biochem., 78, 959 (2009)
  6. Hutt D.M., FEBS Lett., 583, 2639 (2009)
  7. Gregersen N., J. Inherit. Metab. Dis., 29, 456 (2006)
  8. Marks P.A., Nat. Biotechnol., 25, 84 (2007)
  9. Haberland M., Nat. Rev. Genet., 10, 32 (2009)
  10. Scroggins B.T., Mol. Cell, 25, 151 (2007)
  11. Ozcan U., Science, 313, 1137 (2006)
  12. Adcock I.M., Curr. Opin. Immunol., 19, 694 (2007)
  13. Lin H.S., Br. J. Pharmacol., 150, 862 (2007)
  14. Westerheide S.D., Science, 323, 1063 (2009)
  15. Fischle W., J. Biol. Chem., 276, 35826 (2001)
  16. Wang X., Cell, 127, 803 (2006)
  17. Kovacs J.J., Mol. Cell, 18, 601 (2005)
  18. Bebok Z., J. Physiol. (Lond.), 569, 601 (2005)
  19. Lukacs G.L., EMBO J., 13, 6076 (1994)
  20. Gentzsch M., Mol. Biol. Cell, 15, 2684 (2004)
  21. Lahm A., Proc. Natl. Acad. Sci. USA, 104, 17335 (2007)
  22. Marks P.A., Expert Opin. Investig. Drugs, 14, 1497 (2005)
  23. Blander G., Annu. Rev. Biochem., 73, 417 (2004)
  24. Milne J.C., Curr. Opin. Chem. Biol., 12, 11 (2008)
  25. Caci E., Biochem. J., 413, 135 (2008)
  26. Ekins S., Methods Mol. Biol., 356, 319 (2007)
  27. Sun F., J. Biol. Chem., 281, 36856 (2006)
  28. Wang X., Traffic, 9, 1878 (2008)
  29. Wang X., J. Cell Biol., 167, 65 (2004)
  30. Wiseman R.L., Cell, 131, 809 (2007)
  31. Guggino W.B., Nat. Rev. Mol. Cell Biol., 7, 426 (2006)
  32. Dokmanovic M., Mol. Cancer Ther., 6, 2525 (2007)
  33. Chang S., Cell, 126, 321 (2006)
  34. Kasler H.G., Mol. Cell. Biol., 27, 5184 (2007)
  35. Amaral M.D., Pediatr. Pulmonol., 39, 479 (2005)
  36. Yoo J.S., J. Biol. Chem., 277, 11401 (2002)
  37. Mai A., Expert Opin. Ther. Targets, 11, 835 (2007)
  38. Herman D., Nat. Chem. Biol., 2, 551 (2006)
  39. Mai A., Mol. Pharmacol., 72, 1111 (2007)
  40. Westphal C.H., Trends Biochem. Sci., 32, 555 (2007)
  41. Bates E.A., J. Neurosci., 26, 2830 (2006)
  42. Rubenstein R.C., J. Clin. Invest., 100, 2457 (1997)
  43. Singh O.V., J. Proteome Res., 5, 562 (2006)
  44. RUBENSTEIN RONALD C., ZEITLIN PAMELA L., A Pilot Clinical Trial of Oral Sodium 4-Phenylbutyrate (Buphenyl) in Δ F508-Homozygous Cystic Fibrosis Patients : Partial Restoration of Nasal Epithelial CFTR Function, 10.1164/ajrccm.157.2.9706088
  45. Mroz R.M., J. Physiol. Pharmacol., 58, 453 (2007)
  46. Lei D.C., Gene Ther., 3, 427 (1996)
  47. Devor D.C., Am. J. Physiol. Cell Physiol., 279, C461 (2000)
  48. Butterworth M.B., J. Gen. Physiol., 125, 81 (2005)
  49. Myerburg M.M., J. Biol. Chem., 281, 27942 (2006)
  50. Myerburg M.M., Am. J. Physiol. Lung Cell. Mol. Physiol., 294, L932 (2008)